10-K

Company

Hepion Pharmaceuticals, Inc.

Filed

September 29, 2014

Period of Report

June 30, 2014

Accession Number

0001047469-14-007919

A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →